Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause‐Steinrauf et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

Kenneth R. Carson, Andrew M. Evens, Elizabeth Richey et al. · Blood · 2009 · 866 citations · Full text

T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura

Bob Olsson, Per‐Ola Andersson, Margareta Jernås et al. · Nature Medicine · 2003 · 658 citations

Thrombopoiesis, Thrombosis, Blood Platelet +8

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

James Edwards, Geraldine Cambridge · Lara D. Veeken · 2001 · 517 citations · Full text

Clinical Immunology, Immunology, Immune Regulation +17

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

Maria Leandro · Annals of the Rheumatic Diseases · 2002 · 339 citations · Full text